11-Day Sell-Off Sends Ecolab Stock Down -12%
Ecolab (ECL) – a provider of water treatment, hygiene, and infection prevention solutions – hit a 11-day losing streak, with cumulative losses over this period amounting to -12%. The company’s market cap has crashed by about $10 Bil over the last 11 days and currently stands at $77 Bil.
Is this opportunity or trap? There are a few things to fear in ECL stock given its overall Moderate operating performance and financial condition. But keeping in mind its High valuation, we think that the stock is Unattractive (For details, see Buy or Sell ECL).
But here is the interesting part. You are reading about this -12% move after it happened. The market has already priced in the news. To manage individual stock risk before the headlines, you need predictive signals, not notifications. High Quality Portfolio has a risk model designed to manage stock-specific drawdowns better.
Returns vs S&P 500
- How To Earn 9.2% Yield While Waiting to Buy LLY 30% Cheaper
- Could Accenture Stock’s Cash Flow Spark the Next Rally?
- Years of Rewards: $35 Bil From Charter Communications Stock
- McDonald’s Stock Capital Return Hits $35 Bil
- Palo Alto Networks Stock at Support Zone – Bargain or Trap?
- Super Micro Computer Stock Pulls Back to Support – Smart Entry?
The following table summarizes the return for ECL stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | ECL | S&P 500 |
|---|---|---|
| 1D | -0.7% | 1.0% |
| 11D (Current Streak) | -11.7% | -2.6% |
| 1M (21D) | -9.4% | -2.0% |
| 3M (63D) | 4.2% | -2.9% |
| YTD 2026 | 3.8% | -2.1% |
| 2025 | 13.2% | 16.4% |
| 2024 | 19.3% | 23.3% |
| 2023 | 37.9% | 24.2% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: ECL Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 42 S&P constituents with 3 days or more of consecutive gains and 36 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 32 | 17 |
| 4D | 10 | 5 |
| 5D | 0 | 4 |
| 6D | 0 | 6 |
| 7D or more | 0 | 4 |
| Total >=3 D | 42 | 36 |
Key Financials for Ecolab (ECL)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $15.7 Bil | $16.1 Bil |
| Operating Income | $2.6 Bil | $2.9 Bil |
| Net Income | $2.1 Bil | $2.1 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ3 | 2025 FQ4 |
|---|---|---|
| Revenues | $4.2 Bil | $4.2 Bil |
| Operating Income | $786.4 Mil | $786.6 Mil |
| Net Income | $585.0 Mil | $563.9 Mil |
The losing streak ECL stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.